NIA COVID-19 Response

In this rapidly evolving crisis, NIA supports research into COVID-19 and older adults, particularly why they may be more susceptible to the virus, how they can be most protected, and the social and economic effects of the pandemic on older adults.

In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health, including NIA Director Richard J. Hodes, set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease. NIH established the Rapid Acceleration of Diagnostics (RADx) program to respond to this critical need.

The National Institutes of Health’s Rapid Acceleration of Diagnostics (RADxSM) Program

The RADx initiative is a national call for scientists and organizations to bring their innovative ideas for new COVID-19 testing approaches and strategies. NIA has been an integral part of these initiatives, especially the RADx Underserved Populations (RADx-UP) program, which strives to understand the factors associated with disparities in COVID-19 morbidity and mortality. Learn more about RADx.

Check this page frequently for updates on NIA’s response to the COVID-19 pandemic.

NIA is Funding Aging Research into COVID-19

In April, NIA published a Notice of Special Interest (NOSI) on NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19), NOT-AG-20-022. Open to NIA, National Institute of Mental Health, and National Institute on Alcohol Abuse and Alcoholism grantees, the NOSI is designed to support administrative and revision supplements in aging biology, behavioral and social research, geriatrics and gerontology and neuroscience related to COVID-19. Learn more about the NOSI in this Inside NIA blog post.

COVID-19 Funding Opportunities from NIA
Number	Title	Release Date	Expiration Date
NOT-AG-20-129	Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome NOT-AG-20-055: Notice of NIA Withdrawal from Participation in NOT-OD-20-129 “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome”	November 10, 2020	July 13, 2021 (NIA Expiration: December 1, 2020)
NOT-AG-20-022	Notice of Special Interest (NOSI) on NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-AG-20-054: NIA Withdraws Participation in NOT-AG-20-022 - NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Read Frequently Asked Questions about this NOSI. NOT-AG-20-054: NIA Withdraws Participation in NOT-AG-20-022 - NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	April 2, 2020	May 1, 2021 (NIA Expiration: December 1, 2020)
PAR-20-234	NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)	June 15, 2020	February 2, 2021
NOT-AG-21-015	Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)	January 26, 2021	May 8, 2023

In addition to soliciting applications for administrative supplements, NIA has joined the following Notices, NOSIs, and FOAs originating with other NIH Institutes and Centers:

COVID-19 Notices, NOSIs, and FOAs from NIA
Number	Title	Participating Organizations	Release Date	Expiration Date
RFA-OD-20-018	Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)	OD, NHLBI, NHGRI, NIA, NIDCR, NIDA, NCATS, Common Fund, NCI	August 6, 2020	September 19, 2020
RFA-OD-20-014	Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)	OD, NIA, NIAAA, NICHD, NCCIH, NCI, NHLBI	August 6, 2020	September 16, 2020
NOT-OD-20-152	Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool	OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, ORWH	August 6, 2020	September 16, 2020
RFA-OD-20-022	Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)	OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, NLM, ORWH	August 6, 2020	September 16, 2020
PAR-20-243	Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)	NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NIMHD, NCCIH, NCATS, ODP, OBSSR, ORWH, SGMRO	June 26, 2020	March 3, 2021
PAR-20-237	Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	NIMHD, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NINR, NCCIH, NCATS, SGMRO, ODP, ORWH	June 17, 2020	December 2, 2020
NOT-OD-20-119	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH	June 12, 2020	September 9, 2020
NOT-OD-20-120	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH	June 12, 2020	September 9, 2020
NOT-OD-20-121	Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, National Institute of Allergy and Infectious Diseases (NIAID), NIAMS, NICHD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, National Institute of Neurological Disorders and Stroke (NINDS), NINR, NLM, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH	June 12, 2020	August 8, 2020
NOT-OD-20-118	Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency	Office of the Director (OD)	June 10, 2020	N/A
NOT-MD-20-022	Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations NOT-AG-20-060: Notice of NIA Withdrawal from Participation in NOT-MD-20-022, "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations"	NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NCCIH, NCATS, SGMRO, ODP, OBSSR, ORWH	June 5, 2020	December 30, 2020 (NIA Expiration: December 1, 2020)
NOT-MH-20-053	Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 NOT-AG-20-059: Notice of NIA Withdrawal from Participation in NOT-MH-20-053, "Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19"	NIMH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NINR, NIMHD, NCCIH, National Center for Advancing Translational Sciences (NCATS), Sexual and Gender Minority Research Office (SGMRO), OBSSR, ODP, Office of Research on Women's Health (ORWH)	June 5, 2020	December 30, 2020 (NIA Expiration: December 1, 2020)
NOT-MH-20-058	Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional)	NIMH, National Eye Institute (NEI), NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NCCIH, ODP, OBSSR	June 4, 2020	N/A
NOT-MD-20-023	Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	NIMHD, NIA, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Dental and Craniofacial Research (NIDCR), National Institute on Drug Abuse (NIDA), NIEHS, NIMH, National Institute of Nursing Research (NINR), NCCIH, Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP), OBSSR, ORWH	June 3, 2020	N/A
NOT-OD-20-097	Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NOT-AG-20-058: Notice of NIA Withdrawal from Participation in NOT-OD-20-097 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences”	NIH Office of Behavioral and Social Sciences Research (OBSSR), National Heart, Lung, and Blood Institute (NHLBI), NIA, NIAAA, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Environmental Health Sciences (NIEHS), NCCIH, National Cancer Institute (NCI)	April 13, 2020	April 1, 2021 (NIA Expiration: December 1, 2020)
NOT-AT-20-011	Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019	National Center for Complementary and Integrative Health (NCCIH), NIA, NIAAA	April 10, 2020	N/A
NOT-MD-20-019	Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NOT-AG-20-056: Notice of NIA Withdrawal from Participation in NOT-MD-20-019 "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities"	NIMHD, NIA, NIMH, NIAAA, NINDS	April 9, 2020	May 1, 2021 (NIA Expiration: December 1, 2020)
NOT-MH-20-047	Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NOT-AG-20-057: Notice of NIA Withdrawal from Participation in NOT-MH-20-047 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus”	NIMH, NIA, National Institute of Minority Health and Health Disparities (NIMHD), NIAAA	April 9, 2020	April 16, 2021 (NIA Expiration: December 1, 2020)
NOT-AG-20-022	Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)	National Institute on Aging (NIA), National Institute of Mental Health (NIMH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)	April 2, 2020	May 1, 2021

Support for COVID-19 Interruptions for Funded Researchers

The pandemic and associated closures at institutions around the world present significant challenges for funded researchers managing existing studies. NIA is working with NIH and other HHS colleagues to help ease this burden and provide guidance and policies to ensure research can continue as much as is safe during the pandemic and resume with minimal negative impact after this crisis is over. After visiting the OER Coronavirus webpage for the latest guidance from NIH, NIA grantees are encourage to contact their program officers with specific questions.